心臓再同期療法ペースメーカ(CRT-P)の世界市場2016-2020

◆英語タイトル:Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020
◆商品コード:IRTNTR8951
◆発行会社(調査会社):Technavio
◆発行日:2016年7月15日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、心臓再同期療法ペースメーカ(CRT-P)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、心臓再同期療法ペースメーカ(CRT-P)の世界市場規模及び予測、地域別分析/市場規模、主要国別分析、市場の成長要因、市場の課題、コスト分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Cardiac Resynchronization Therapy-pacemaker (CRT-P)
CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart’s rhythm to improve breathlessness and fatigue, and avoid dizziness and fainting in individuals.
Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side of the heart to stimulate the left ventricle, assisting the heart to pump efficiently.
Technavio’s analysts forecast the global cardiac resynchronization therapy-pacemaker (CRT-P) market to grow at a CAGR of 8.17% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy-pacemaker (CRT-P) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of CRT-Ps.

The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC

Technavio’s report, Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BIOTRONIK
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical

[Market driver]
• Implementation of minimally invasive procedures
• For a full, detailed list, view our report

[Market challenge]
• Risk of potential complications
• For a full, detailed list, view our report

[Market trend]
• Popularity of robot-assisted cardiac surgery
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Cost analysis of CRT-Ps and implantation

PART 07: Geographical segmentation
• CRT-P market in Americas
• CRT-P market in EMEA
• CRT-P market in APAC

PART 08: Key leading countries
• US
• France
• UK
• Germany

PART 09: Market drivers
• Incidence of cardiovascular diseases
• Government-aided awareness programs
• Implementation of minimally invasive procedures
• Demand for CRT-Ps in APAC

PART 10: Impact of drivers

PART 11: Market challenges
• Presence of alternatives
• Lack of skilled personnel
• Risk of potential complications
• Limitations of CRT-Ps in pediatric patients

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Focus on R&D and clinical trials
• Popularity of robot-assisted cardiac surgery
• Focus on leadless CRT-Ps

PART 14: Vendor landscape
• Competitive scenario

PART 15: Key vendor analysis
• BIOTRONIK
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global CRT-P market 2015-2020 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of CRT-P and ICD and their implantation
Exhibit 05: Global CRT-P market segmentation by geography 2015
Exhibit 06: Global CRT-P market segmentation by geography 2020
Exhibit 07: Global CRT-P market segmentation by geography 2015-2020
Exhibit 08: CRT-P market in Americas 2015-2020 ($ millions)
Exhibit 09: CRT-P market in EMEA 2015-2020 ($ millions)
Exhibit 10: CRT-P market in APAC 2015-2020 ($ millions)
Exhibit 11: CRT-P market in US 2015-2020 ($ millions)
Exhibit 12: CRT-P market in France 2015-2020 ($ millions)
Exhibit 13: CRT-P market in UK 2015-2020 ($ millions)
Exhibit 14: CRT-P market in Germany 2015-2020 ($ millions)
Exhibit 15: Impact of drivers
Exhibit 16: Impact of drivers and challenges
Exhibit 17: BIOTRONIK: Product portfolio
Exhibit 18: BIOTRONIK: Key takeaways
Exhibit 19: Boston Scientific: Cardiac rhythm management segmentation by revenue 2015
Exhibit 20: Boston Scientific: Cardiac rhythm management segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 21: Boston Scientific: Geographical segmentation of cardiac rhythm management by revenue 2015
Exhibit 22: Key takeaways: Boston Scientific
Exhibit 23: LivaNova: Product portfolio
Exhibit 24: LivaNova: Key takeaways
Exhibit 25: Medtronic: Product portfolio
Exhibit 26: Key takeaways: Medtronic
Exhibit 27: St. Jude Medical: Product portfolio
Exhibit 28: Key takeaways: St. Jude Medical



【掲載企業】

BIOTRONIK, Boston Scientific, LivaNova, Medtronic, St. Jude Medical

【レポートのキーワード】

心臓再同期療法ペースメーカ(CRT-P)、心臓再同期療法、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[心臓再同期療法ペースメーカ(CRT-P)の世界市場2016-2020]販売に関する免責事項
★調査レポート[心臓再同期療法ペースメーカ(CRT-P)の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆